Document is current
Any future updates will be listed below
-
Authors
Versfeld, Anna http://orcid.org/0000-0002-6741-8095
McBride, Angela
Scheibe, Andrew
Spearman, C. Wendy
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb Foundation
- License Information
-
More Information
Article History
Received: 1 August 2019
Accepted: 26 May 2020
First Online: 10 June 2020
Ethics approval and consent to participate
: Research was approved by the University of Cape Town Human Research Ethics Committee (reference number 320/2017). Participation was entirely voluntary and written informed consent was obtained from all study participants. The extreme vulnerability of the study population was taken into account through careful efforts to maintain privacy and confidentiality.
: All participants consented to their interview data being used for publication, based on the removal of identifying features, and the use of pseudonyms, as has been done.
: AS is a faculty member of the Bristol-Myers Squibb Foundation and has received an honorarium from Gilead Pharmaceuticals to present hepatitis prevalence data at a South African conference for HIV clinicians. There are no competing interests to declare for the other authors.
